Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Shareholder vote
confidence 98%
filed 2026-06-25
Item 5.07
This is a clear disclosure of shareholder vote results from Liberty Global's June 23, 2026 annual general meeting, covering four proposals: election of three directors (Miranda Curtis CMG, J David Wargo, Anthony G. Werner), appointment of KPMG LLP as auditors, advisory approval of named executive officer compensation, and frequency of future say-on-pay votes. The filing provides detailed vote tallies and confirms all resolutions passed, with the say-on-pay frequency set at three years. This is a quintessential Item 5.07 disclosure and is material to investors as it documents shareholder approval of board composition and governance matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-25
Item 5.07
This is a clear Item 5.07 disclosure of shareholder voting results from Synchrony Financial's 2026 Annual Meeting held on June 24, 2026. The filing reports detailed vote tallies for three proposals: election of all 12 directors, ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with substantial majorities, making this a routine but material governance disclosure that affects investor understanding of board composition and shareholder sentiment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-25
Item 5.07
This is a clear disclosure of shareholder vote results from AquaBounty's Annual Meeting of Stockholders held on June 23, 2026, covering five proposals: director elections, auditor ratification, reverse stock split authorization, executive compensation approval, and meeting adjournment. The filing presents final voting tallies for each proposal, which is the quintessential content of Item 5.07 shareholder vote results disclosures. The reverse stock split authorization (Proposal 3) is particularly material as it grants the Board discretion to effect a 1-for-5 to 1-for-20 reverse split by July 31, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-25
Item 2.02
Atlantic International disclosed first quarter 2026 financial results via press release on June 22, 2026, reporting revenue of $249.9 million (143% increase year-over-year) and gross profit of $21.4 million (92% increase), reflecting the impact of the Circle8 acquisition completed January 23, 2026.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-25
Item 7.01
Seven Stars B.V., a subsidiary within the Circle8 Group acquired by Atlantic International, was awarded a four-year framework agreement by the Dutch Vehicle Authority with a minimum value of approximately $52 million, representing a material commercial milestone and significant addition to the company's revenue pipeline.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 92%
filed 2026-06-25
Item 8.01
Nasdaq notified the Company that it has regained compliance with Nasdaq Listing Rule 5250(c)(1) following the filing of its Form 10-Q, resolving a prior delinquency in timely filing of periodic reports that had threatened the Company's continued listing.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-06-25
Item 7.01
ZipRecruiter announced a material debt repurchase transaction involving approximately $295 million in principal amount of its 5% senior unsecured notes due 2030, to be repurchased for approximately $230 million plus accrued interest. While this is technically a debt reduction rather than issuance, the event involves a significant modification of the company's direct financial obligations and capital structure. The transaction is material—reducing outstanding debt by over half and capturing a $65 million discount—and affects the registrant's financial position. This is best classified as a debt-related financial event; however, the taxonomy's `debt_issuance` category is designed for creation of new obligations, whereas this is a retirement of existing debt. The closest fit is `financial_other` since the event is clearly financial and material but involves debt retirement rather than issuance.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-06-25
Item 5.03
This disclosure concerns a certificate of amendment to the Company's Certificate of Incorporation filed on June 24, 2026, which amended Article IV to authorize a new capital structure and effect a recapitalization converting outstanding shares into 316,939,750 shares. While the recapitalization is part of a broader spin-off distribution plan, the Item 5.03 filing itself focuses on the governance/charter amendment mechanics rather than the M&A activity itself. The amendment is material to investors as it restructures the Company's capitalization in connection with the announced distribution, but it is fundamentally a governance/charter matter rather than a specific M&A event type.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-25
Item 2.02
TD SYNNEX issued a press release on June 25, 2026 disclosing financial results for fiscal Q2 2026 ended May 31, 2026, including revenue of $19.6 billion (31.0% YoY growth), diluted EPS of $4.15 (87.8% YoY growth), and non-GAAP diluted EPS of $4.85 (62.2% YoY growth), all significantly exceeding guidance. The filing also announces a quarterly dividend of $0.48 per share. This is a standard earnings release disclosure under Item 2.02 that would materially affect a reasonable investor's assessment of the company's financial performance and capital allocation.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-25
Item 5.02
NeoGenomics appointed Carolyn S. Starrett as a director to fill a newly created board vacancy, effective June 23, 2026. Ms. Starrett brings 25+ years of executive experience, including a decade as CEO of Flatiron Health and prior roles at Foundation Medicine and Boston Consulting Group, making this a material addition to the Board's composition and expertise.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-25
Item 2.02
Winnebago Industries issued a press release on June 25, 2026, reporting third-quarter Fiscal 2026 financial results for the period ended May 30, 2026. The disclosure includes net revenues of $698.7 million, net income of $14.5 million ($0.51 per diluted share), and adjusted EBITDA of $37.8 million, along with segment performance summaries and updated full-year guidance. This is a standard quarterly earnings release attached as Exhibit 99.1 and disclosed under Item 2.02, which is material to investors assessing the company's financial performance and forward outlook.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-06-25
Item 8.01
The filing discloses a quarterly cash dividend declaration of $0.3575 per share ($1.43 annualized), representing the 33rd consecutive annual increase. While the press release references recent financial results and AI momentum, the primary disclosed action under Item 8.01 is the Board's declaration of a dividend payable to shareholders, which is a material capital allocation decision affecting investor returns.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-25
Item 5.07
This is a clear disclosure of shareholder voting results from Red Cat Holdings' 2026 Annual Meeting held on June 18, 2026. The filing reports results for three proposals: election of five directors, ratification of KPMG LLP as independent auditor, and a non-binding advisory vote on executive compensation. The disclosure includes vote counts (For, Against, Withheld, Abstentions, Broker Non-Votes) for each proposal, which is the hallmark of Item 5.07 shareholder vote results. Notably, Proposal 3 (say-on-pay) failed to receive majority support, which is material information for investors assessing governance and compensation alignment.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-25
EX-99.1
The exhibit discloses the results of Valneva's Annual General Meeting held on June 25, 2026, including shareholder approval of all Board-recommended resolutions (2025 financial statements, board authorizations, office relocation) and reappointment of five Board members. Additionally, Dr. Gerd Zettlmeissl was appointed as Chair of the Board following the AGM, succeeding Anne-Marie Graffin. This is a material governance event affecting board leadership and shareholder-approved strategic decisions.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 90%
filed 2026-06-25
Item 5.02
Patrick Keenan was appointed as Chief Financial Officer of AlTi Global, Inc., effective July 1, 2026, promoted from Deputy CFO. The appointment follows the planned retirement of Michael Harrington and includes a compensation package of $375,000 salary plus $450,000 target bonus.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-25
Item 1.01
Affirm entered into Amendment No. 4 to its Revolving Credit Agreement on June 18, 2026, increasing the aggregate commitment from $330 million to $675 million and extending the maturity to June 18, 2029, materially expanding the company's credit facility and liquidity.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-25
Item 5.02
Ryan Schneider was appointed as a Class III director to Affirm's Board effective July 1, 2026, and appointed to the Audit Committee and Nominating and Governance Committee, bringing significant executive experience from his prior roles as CEO of Anywhere Real Estate and President of Card Business at Capital One.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-25
Item 5.07
This is a clear disclosure of shareholder vote results from the June 24, 2026 annual meeting of stockholders. The filing reports voting outcomes for two proposals: (1) election of nine directors with detailed vote tallies for each nominee, and (2) ratification of MaloneBailey, LLP as independent auditor. This is the quintessential Item 5.07 disclosure and is material to investors as it confirms board composition and auditor selection.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-25
Item 5.07
This is a clear disclosure of shareholder voting results from Ellington Credit Company's annual meeting held on June 25, 2026. The filing reports final voting tallies for two proposals: election of six trustees and ratification of PricewaterhouseCoopers LLP as independent auditors. The detailed vote counts (For, Against/Withheld, Broker Non-Votes) are the core content of Item 5.07, which is the standard Item for reporting shareholder meeting results.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-25
Item 3.02
Ares Sports, Media & Entertainment Opportunities LP completed an unregistered private placement of approximately $34.2 million in limited partnership units across multiple unit classes (Class S, Class I, Class A-S, Class A-D, and Class A-I) to accredited investors and qualified purchasers under Section 4(a)(2) and Regulation D.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-25
Item 2.02
FedEx Freight disclosed segmented financial results for the fourth quarter and full fiscal year ended May 31, 2026 via a press release dated June 25, 2026, attached as Exhibit 99.1. The disclosure includes revenue, operating income, operating margins, and forward guidance for the transition period, which are hallmark elements of an earnings release under Item 2.02. The company also noted its recent spin-off from FedEx Corporation and began trading independently on June 1, 2026, making this the first standalone earnings announcement as a public company.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-25
Item 5.07
This Item 5.07 disclosure reports the final voting results from Arvinas' June 24, 2026 annual meeting of stockholders on three proposals: election of two Class II directors (Leslie V. Norwalk, Esq. and Randy Teel, Ph.D.), advisory approval of named executive officer compensation, and ratification of Deloitte & Touche LLP as independent auditor. The filing presents tabulated vote counts (For, Against, Abstain, Broker Non-Votes) for each proposal, which is the standard format for shareholder vote result disclosures under Item 5.07.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-25
Item 1.01
Ingredion entered into a $1.475 billion Delayed Draw Term Loan Agreement on June 24, 2026, to finance its announced acquisition of Tate & Lyle PLC, refinance Tate & Lyle's debt, and cover acquisition-related fees and expenses.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-06-25
Item 7.01
Ellington Financial announced its estimated book value per share of $13.49 as of May 31, 2026, along with a monthly dividend of $0.13 per share. This is a financial disclosure of net asset value and dividend information material to shareholders of a mortgage REIT, but it does not fit the specific categories of earnings_release (no full quarterly/annual results), dividend_distribution (the dividend was previously announced), or other named financial event types. The disclosure is clearly financial in nature and material to investors assessing the company's value, making financial_other the most appropriate classification.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-25
Item 2.02
This is a clear earnings release disclosing Quantum Corporation's fiscal fourth quarter and full year 2026 financial results as of March 31, 2026. The Item 2.02 section explicitly states "Quantum Corporation (the 'Company') reported its financial results for the fiscal quarter ended March 31, 2026" with the earnings release furnished as Exhibit 99.1. The exhibit contains detailed financial statements, revenue growth of 27% year-over-year, and forward guidance for Q1 FY2027, all hallmarks of a quarterly earnings disclosure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-06-25
Item 1.01
Floor & Decor's subsidiary F&D entered into two new senior secured credit facilities on June 24, 2026: a $200 million term loan facility maturing in 2033 and an $800 million revolving ABL facility maturing in 2031, refinancing and replacing its prior term loan and ABL facilities. The transaction creates $1 billion in new direct financial obligations with specified interest rates, maturity dates, covenants, and security interests.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-25
Item 5.07
Marvell held its Annual Meeting of Stockholders on June 25, 2026, with voting results showing all seven director nominees elected, advisory say-on-pay approval, ratification of Deloitte & Touche LLP as auditor, and rejection of a stockholder proposal on independent board chairman.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-06-25
Item 8.01
Marvell declared a quarterly dividend of $0.06 per share, payable on July 30, 2026 to stockholders of record as of July 10, 2026.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-25
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Rhythm Pharmaceuticals' Annual Meeting of Stockholders held on June 24, 2026. The filing presents voting outcomes for three proposals: election of two Class III Directors (David W. J. McGirr and David P. Meeker, MD), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed. Shareholder votes on director elections and auditor ratification are material governance events affecting investor assessment of board composition and audit oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-25
Item 5.07
Gates Industrial shareholders approved a scheme of arrangement to redomicile the company from England and Wales to Bermuda at Court and General Meetings held on June 25, 2026, including approval of the Scheme, reduction of capital, issuance of new shares on a one-for-one basis, and articles amendments.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-25
Item 7.01
Gates Industrial shareholders approved a redomiciliation scheme involving a change of domicile from England and Wales to Bermuda with issuance of new shares on a one-for-one basis, constituting a material change of control and corporate restructuring.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-25
Item 8.01
Gates Industrial disclosed the implementation timeline for the shareholder-approved redomiciliation, including court hearing dates, scheme record time, delisting of existing shares, and listing of new shares on the Bermuda exchange.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-06-25
Item 7.01
James Hardie redeemed US$400 million of 5.00% Senior Unsecured Notes due 2028 on June 25, 2026. While this is technically a debt retirement rather than issuance, the redemption of a material debt obligation represents a significant financial event affecting the company's capital structure and liquidity position. The materiality of the $400 million principal amount and the public announcement via press release indicate this is a material disclosure to investors regarding the company's direct financial obligations.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-25
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 23, 2026, filed under Item 5.07. The filing reports voting outcomes for three proposals: election of directors Michael Alfred and Lyn Alden, advisory approval of named executive officer compensation, and ratification of Grant Thornton LLC as independent auditors, with detailed vote tallies for each matter. This is a material governance event affecting investor understanding of board composition and shareholder approval of key corporate matters.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-25
Item 5.02
Daren Thayne, Chief Technology Officer and Executive Vice President of Product, notified the Company of his resignation effective July 10, 2026, to accept another executive position. This is a clear departure of a named executive officer. While the filing notes the company does not plan to immediately replace him due to potential transaction negotiations, the principal disclosed action is the officer's departure, making exec_departure the most salient classification.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-25
Item 5.02
Sudhanshu Priyadarshi was appointed as Chief Financial Officer and President, International, effective June 25, 2026. The appointment includes compensatory arrangements with a base salary of $900,000, target bonus of 115%, and equity awards totaling $7,000,000. Tom Fitzgerald's role as Interim CFO concluded with this appointment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-25
Item 5.02
The filing discloses both the resignation of Ms. Dandan Chen as Director and CEO and the election of Liao Xiu Ze as CEO. While both events occur, the principal disclosed action centers on the appointment of a new CEO—Liao Xiu Ze was elected to the CEO role in addition to his existing CFO, Treasurer, and Secretary positions. This is a material leadership transition affecting the company's chief executive officer position.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-25
EX-99.1
This press release announces pivotal Phase II clinical trial results for fanregratinib (HMPL-453) in intrahepatic cholangiocarcinoma, demonstrating an objective response rate of 42.5% and median overall survival of 16.6 months. The trial has met its primary endpoint, and the New Drug Application has been accepted for priority review by China's NMPA in December 2025. This is a material clinical and regulatory milestone for a key drug candidate, but it is not a discrete financial event (earnings release), M&A activity, executive change, or other specifically enumerated event type—it is a significant operational/clinical development that would affect investor assessment of the company's pipeline and commercial prospects.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 75%
filed 2026-06-25
Lloyds Banking Group announces redemption of $1.5 billion in 5.985% Senior Callable Fixed-to-Fixed Rate Notes due 2027 and $500 million in Senior Callable Floating Rate Notes due 2027, to be redeemed on August 7, 2026 at 100% of principal plus accrued interest. While technically a redemption (retirement) of existing debt rather than issuance of new debt, this represents a material modification of the Group's direct financial obligations and capital structure. The redemption of $2 billion in aggregate principal is a significant financial event affecting the Group's debt profile and liquidity position.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-25
Item 1.01
WidePoint was selected as the single awardee of a 10-year DHS Cellular Wireless Managed Services (CWMS) 3.0 contract with a ceiling value of approximately $3.1 billion. While this is technically a government contract award rather than a traditional M&A transaction, it represents a material entry into a definitive agreement that will substantially alter the company's business scope and revenue trajectory. The Item 1.01 classification and the contract's scale ($3.1B ceiling) support treating this as a material business development event most closely aligned with ma_activity in the taxonomy.
View raw filing on EDGAR →
6-K
Operational Other
confidence 72%
filed 2026-06-25
Barclays PLC discloses the Federal Reserve Board's publication of annual bank stress test results for Barclays US LLC, noting that projected capital ratios remained above regulatory minimum levels across all nine quarters tested. This is a regulatory compliance disclosure of material supervisory stress-test results that would affect a reasonable investor's assessment of the registrant's capital adequacy and regulatory standing, but it does not fit neatly into the standard event taxonomy (not a restatement, impairment, covenant breach, or going-concern disclosure). It is operational/regulatory in nature rather than a discrete financial event.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-25
Item 2.03
The filing discloses the creation of a direct financial obligation through the issuance of consolidated obligation bonds. Schedule A reports a $100 million fixed-rate bond (CUSIP 3130BBBR5) with a trade date of 6/22/2026 and maturity of 10/7/2027, representing a new debt obligation for which the Federal Home Loan Bank of New York is the primary obligor. This is a classic debt issuance disclosure under Item 2.03.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-25
Item 3.02
Beyond Meat entered into warrant agreements with Big Geyser on June 22, 2026, granting rights to purchase up to 4,166,667 shares of common stock at exercise prices of $0.60 and $0.001 per share through a private placement relying on Section 4(a)(2) exemption. The warrants feature weighted average anti-dilution provisions and net-share settlement options, representing a dilutive equity financing arrangement.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-25
Item 8.01
The filing discloses entry into a Binding Memorandum of Understanding to acquire a 51% controlling interest in ULTRANET Telecom Group, described as "the largest transaction in IQSTEL's history." The transaction is expected to add $130M in annual revenue (~30% increase), $4.5M in net income (~4x multiplier), and $13M in shareholders' equity. This is a material acquisition meeting the definition of ma_activity under Item 8.01 (Other Events), though typically such transactions are disclosed under Item 1.01 or 2.01.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-25
Item 5.02
Keros Therapeutics appointed Anne Prener, M.D., Ph.D., as a director effective July 1, 2026. Dr. Prener brings significant clinical development and executive leadership experience to the Board. Her compensation package includes initial and annual equity grants totaling $300,000 in grant-date fair value plus a $41,500 annual cash retainer.
View raw filing on EDGAR →
8-K
M&A activity
confidence 75%
filed 2026-06-25
Item 1.01
Unusual Machines announced a planned acquisition of Upgrade Energy, expected to close by mid-Q3 2026. The company simultaneously entered into a lease for a 14,000-square-foot manufacturing facility in Orlando, Florida to expand domestic battery production capacity in connection with the anticipated acquisition.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-25
Item 5.02
Craig Harris was appointed as a director of Kinetik Holdings Inc., effective June 23, 2026, increasing the Board size from 10 to 11 directors. Harris brings 30+ years of energy industry experience and senior leadership roles at Blackstone, Enable Midstream Partners, and El Paso Corporation.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-25
Item 1.01
Liberty Energy entered into a $332.6 million equipment supply contract with Wärtsilä for power generation equipment to support prospective data center and distributed power projects. While this is a material contract disclosed under Item 1.01, it does not constitute a merger, acquisition, disposition, or change of control (which would be `ma_activity`), nor does it fit other specific financial or operational categories. The contract is a significant capital commitment for strategic business expansion, making it a material operational event that does not fit a named taxonomy category.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-06-25
Item 8.01
FirstSun completed the sale of approximately $336 million in performing municipal loans acquired from First Foundation Bank and intends to use proceeds to pay down high-cost deposits. This is a material balance sheet repositioning activity following the First Foundation acquisition (closed April 1, 2026), affecting asset composition and liability management. While the sale itself is a financial transaction, it does not fit the specific categories of debt_issuance, dividend_distribution, or material_impairment; it is best classified as a material financial event outside those named categories.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-25
Item 1.01
T Stamp Inc entered into a Note Purchase Agreement with Streeterville Capital LLC on June 25, 2026, issuing a Secured Promissory Note with a principal amount of $5,510,000 (net proceeds of $5,000,000) at 9% per annum, maturing June 25, 2028, and secured by all company assets. This represents a material creation of a new direct financial obligation with significant debt covenants and default triggers.
View raw filing on EDGAR →